Drugs Information Online
Drugs and diseases reference index

Drugs and diseases reference index

Drugs A-Z List

Diseases & Conditions A-Z List

Herbs & Supplements

Medical Dictionary

Full Article

Popular Drugs

Popular Diseases & Conditions

Drugs reference index «Atenolol/Chlorthalidone»

Atenolol / Chlorthalidone

Pronunciation: (ah-TEN-oh-lahl/klor-THAL-ih-dohn)Class: Antihypertensive combination

Trade Names:Tenoretic-50- Tablets 50 mg atenolol/25 mg chlorthalidone

Trade Names:Tenoretic-100- Tablets 100 mg atenolol/25 mg chlorthalidone

Apo-Atenidone (Canada)Tenoretic (Canada)


Atenolol is a beta-adrenergic blocking agent that slows heart rate, reduces cardiac output and lowers BP. Chlorthalidone is a diuretic agent that reduces body water by increasing urine output.

Indications and Usage

Treatment of hypertension.


Hypersensitivity to sulfonamide-derived drugs, sinus bradycardia, heart block greater than first degree, cardiogenic shock, overt cardiac failure, anuria. Not for initial therapy of hypertension.

Dosage and Administration


PO 50 mg atenolol/25 mg chlorthalidone or 100 mg atenolol/25 mg chlorthalidone once daily.


Store at room temperature in tightly closed, light-resistant container.

Drug Interactions


Beta-blockers may exacerbate rebound hypertension associated with clonidine withdrawal. Atenolol/chlorthalidone should be tapered and withdrawn several days before gradual withdrawal of clonidine.

Digitalis glycosides

Diuretic-induced hypokalemia may potentiate digitalis toxicity.


May increase therapeutic and toxic effects of lithium; avoid concomitant use.

Nondepolarizing muscle relaxants

May increase effects of these agents.


May decrease arterial responsiveness to norepinephrine.

Other antihypertensive agents

May increase antihypertensive effects.


May decrease hypoglycemic effects.

Laboratory Test Interactions

May increase serum protein-bound iodine levels without signs of thyroid disturbances.

Adverse Reactions


Bradycardia; orthostatic hypotension; cold extremities; leg pain; CHF; slow atrioventricular (AV) conduction; intensification of AV block.


Fatigue; dizziness; vertigo; light-headedness; lethargy; drowsiness; depression; dreaming.




Diarrhea; nausea.


Peyronie disease; impotence; diminished libido.


Thrombocytopenia; agranulocytosis.


Elevated liver enzymes; jaundice; pancreatitis.


Hyperuricemia; hyponatremia; hypochloremic alkalosis; hypokalemia.


Bronchospasm; wheezing; dyspnea.


Development of lupus syndrome with antinuclear antibodies.



Side effects

Withhold medication and notify health care provider if the following symptoms occur: hypotension; bradycardia or dyspnea; difficulty breathing on exertion or lying down; night cough; edema of hands and feet.


Category D .


Atenolol is excreted in breast milk and may produce clinically significant effects in infants.


Safety and efficacy not established.


Dose may need to be reduced.

Renal Function

Use with caution in patients with renal disease; dose may need to be reduced.

Hepatic Function

Use with caution in patients with hepatic disease; dose may need to be reduced.


Deaths have occurred with anaphylactic reactions to beta-blockers; aggressive therapy may be required.

Cardiac failure

Use with caution in patients with history of heart failure.

Diabetes mellitus

May mask symptoms of hypoglycemia (eg, tachycardia, BP changes). May potentiate insulin-induced hypoglycemia.


Fixed-dose combinations of drugs are not intended for initial therapy of hypertension but are used for convenience once patient has been stabilized.

Nonallergic bronchospastic diseases (eg, chronic bronchitis, emphysema)

In general, do not give beta-blockers to patients with bronchospastic diseases.

Peripheral vascular disease

May precipitate or aggravate symptoms of arterial insufficiency.


May mask clinical signs (eg, tachycardia) of developing or continuing hyperthyroidism. Abrupt withdrawal may exacerbate symptoms of hyperthyroidism, including thyroid storm.

Patient Information

  • Explain that dosage will be tapered slowly before stopping. Warn that sudden discontinuation may cause adverse effects (eg, exacerbation of angina, precipitation of MI).
  • Teach patient proper technique for taking pulse and BP, and instruct to check before taking medication.
  • Advise patient not to take medication in evening to avoid prolonged diuretic effects.
  • Instruct diabetic patient to monitor blood glucose level carefully.
  • Counsel patient that impotence or decrease in libido are common side effects, and advise patient to contact health care provider if either symptom occurs.
  • Caution patient to avoid sudden position changes to prevent orthostatic hypotension.
  • Advise patient that drug may cause drowsiness, and to use caution while driving or performing other tasks requiring mental alertness until individual effects can be determined.

Copyright © 2009 Wolters Kluwer Health.

Comment «Atenolol/Chlorthalidone»